Stockreport

Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase [Read more]